Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI110802

Epinephrine is a Hypophosphatemic Hormone in Man. PHYSIOLOGICAL EFFECTS OF CIRCULATING EPINEPHRINE ON PLASMA CALCIUM, MAGNESIUM, PHOSPHORUS, PARATHYROID HORMONE, AND CALCITONIN

Jean-Jacques Body, Philip E. Cryer, Kenneth P. Offord, and Hunter Heath III

Endocrine Research Unit, Division of Endocrinology and Metabolism, Department of Medicine, Department of Medical Statistics and Epidemiology, Mayo Clinic and Mayo Medical School, Rochester Minnesota 55905

Metabolism Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri

Clinical Research Center, Washington University School of Medicine, St. Louis, Missouri

Diabetes Research and Training Center, Washington University School of Medicine, St. Louis, Missouri

Find articles by Body, J. in: PubMed | Google Scholar

Endocrine Research Unit, Division of Endocrinology and Metabolism, Department of Medicine, Department of Medical Statistics and Epidemiology, Mayo Clinic and Mayo Medical School, Rochester Minnesota 55905

Metabolism Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri

Clinical Research Center, Washington University School of Medicine, St. Louis, Missouri

Diabetes Research and Training Center, Washington University School of Medicine, St. Louis, Missouri

Find articles by Cryer, P. in: PubMed | Google Scholar

Endocrine Research Unit, Division of Endocrinology and Metabolism, Department of Medicine, Department of Medical Statistics and Epidemiology, Mayo Clinic and Mayo Medical School, Rochester Minnesota 55905

Metabolism Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri

Clinical Research Center, Washington University School of Medicine, St. Louis, Missouri

Diabetes Research and Training Center, Washington University School of Medicine, St. Louis, Missouri

Find articles by Offord, K. in: PubMed | Google Scholar

Endocrine Research Unit, Division of Endocrinology and Metabolism, Department of Medicine, Department of Medical Statistics and Epidemiology, Mayo Clinic and Mayo Medical School, Rochester Minnesota 55905

Metabolism Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri

Clinical Research Center, Washington University School of Medicine, St. Louis, Missouri

Diabetes Research and Training Center, Washington University School of Medicine, St. Louis, Missouri

Find articles by Heath, H. in: PubMed | Google Scholar

Published March 1, 1983 - More info

Published in Volume 71, Issue 3 on March 1, 1983
J Clin Invest. 1983;71(3):572–578. https://doi.org/10.1172/JCI110802.
© 1983 The American Society for Clinical Investigation
Published March 1, 1983 - Version history
View PDF
Abstract

The physiologic effects of epinephrine on mineral metabolism are not known. In six healthy men, insulin-induced hypoglycemia, a potent stimulus to endogenous epinephrine secretion, resulted in a decrement of 0.9±0.1 mg/dl (mean±SE, P < 0.001) in serum inorganic phosphorus and smaller increments in magnesium and total and ionized calcium. Plasma immunoreactive parathyroid hormone (iPTH) decreased and plasma immunoreactive calcitonin (iCT) increased appropriately with the increments in calcium and magnesium. We wished to determine to what extent these changes in mineral metabolism might be attributable to epinephrine. Therefore, in the same protocol, we infused the hormone over 60 min in these six men, in doses that resulted in steady-state plasma epinephrine concentrations ranging from 52 to 945 pg/ml (levels that span the physiologic range), for a total of 25 studies. Serum ionized calcium, iPTH, and iCT concentrations were unaltered by these physiologic elevations of plasma epinephrine. However, epinephrine resulted in dose-dependent decrements in serum inorganic phosphorus of 0.6±0.1 mg/dl (P < 0.005) for the highest epinephrine infusion rate. The plasma epinephrine concentration threshold for this hypophosphatemic effect was ∼50-100 pg/ml. Thus, the sensitivity of the hypophosphatemic response to epinephrine is comparable to that of the cardiac chronotropic, systolic pressor, and lipolytic responses to epinephrine, and considerably greater than that of the diastolic depressor, glycogenolytic, glycolytic, and ketogenic responses to the hormone in human beings. In view of its rapidity, the hypophosphatemic effect of epinephrine is probably the result of a net shift of phosphate from the extracellular compartment to intracellular compartments. We suggest that it is a direct effect of epinephrine, in that it is not mediated by changes in availability of the primary regulatory hormones PTH and CT, although indirect effects mediated by changes in other hormones, such as insulin, cannot be excluded. The hypophosphatemic response is also not attributable to increments in plasma calcium. These data indicate that epinephrine in physiologic concentrations is a hypophosphatemic hormone in man.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 572
page 572
icon of scanned page 573
page 573
icon of scanned page 574
page 574
icon of scanned page 575
page 575
icon of scanned page 576
page 576
icon of scanned page 577
page 577
icon of scanned page 578
page 578
Version history
  • Version 1 (March 1, 1983): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts